Litcius/Paper detail

Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives

Rita Meleddu, Serenella Deplano, Elias Maccioni, Francesco Ortuso, Filippo Cottiglia, Daniela Secci, Alessia Onali, Erica Sanna, Andrea Angeli, Rossella Angius, Stefano Alcaro, Claudiu T. Supuran, Simona Distinto

2021Journal of Enzyme Inhibition and Medicinal Chemistry26 citationsDOIOpen Access PDF

Abstract

has been designed and synthesised to investigate the effect of structural modifications on their inhibition ability and selectivity profile towards carbonic anhydrase isoforms I, II, IX, and XII. None of the new compounds exhibited activity towards hCA I and II isozymes. Conversely, both coumarin and psoralen derivatives were active against tumour associated isoforms IX and XII in the low micromolar or nanomolar range of concentration. These data further corroborate our previous findings on analogous derivatives, confirming that both coumarins and psoralens are interesting scaffolds for the design of isozyme selective hCA inhibitors.

Topics & Concepts

CoumarinPsoralenIsozymeCarbonic anhydraseChemistryGene isoformStereochemistrySelectivityEnzymeBiochemistryCombinatorial chemistryOrganic chemistryCatalysisGeneDNAEnzyme function and inhibitionSynthesis and Catalytic ReactionsCholinesterase and Neurodegenerative Diseases
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives | Litcius